Dec 19 | Bio-IT World | Bina Technologies announced this morning that it has been acquired by Roche. Financial details were not disclosed. The Roche acquisition is, “the best outcome that could have happened for our company,” co-founder and CEO Narges Bani Asadi told Bio-IT World today.
Dec 19 | NIH Director's Blog | At the time that we
completed a draft of the 3 billion letters of the human genome
about a decade ago, it would have cost about $100 million to
sequence a second human genome. Today, thanks to advances in DNA
sequencing technology, it will soon be possible to sequence your
genome or mine for $1,000…
Dec 19 | Bio-IT World | Fitting a two-meter strand of DNA into a nucleus a few microns long is no simple thing. The genome isn’t wadded up and stuffed into every cell in the body, it’s folded meticulously. A five-year effort to look at the genome inside cells suggests that these folds may play crucial roles in function.
Dec 18 | Bio-IT World | A new version of a research tool described as the world’s first spatial index to the human proteome is expected to change the nature of drug development, and is already the source of some two external peer-reviewed research papers on average every day, said Professor Mathias Uhlén, at a press conference on Nov. 6 announcing the release of version 13 of the Atlas.
Dec 18 | MIT Technology Review | Scientists are starting to
open their DNA databases online, creating a network that could pave
the way for gene analysis at a new scale.
Dec 17 | Business Weekly | A new genomics powerhouse, 14M
Genomics, spun out of the world famous Wellcome Trust Sanger
Institute, has been launched in the Cambridge UK technology cluster
with a £12.5 million financing.
Dec 17 | Boston Globe | Big pharma is expanding its reach in the Boston area, picking up small to mid-sized biotechs for billions of dollars. Last week Merck announced plans to buy Cubist Pharmaceuticals for $9.5 billion.
Dec 16 | Bio-IT World News Brief | Quanterix today announced the opening of a Simoa Accelerator in Lexington, Mass., where scientists and can rent access to the company's high-throughput Simoa instruments for protein analysis.
Dec 15 | Bio-IT World News Brief | Retraction Watch, a popular blog founded in 2010 to investigate retractions in the scientific literature, has received a two-year grant from the MacArthur Foundation to compile a database of all retractions, corrections, and expressions of concern in every field of science.
Dec 12 | Science/AAAS News | The Smithsonian Institution
plans to launch a virtual biodiversity genomics institute to
catalog DNA from the earth's flora and fauna. To coordinate
biodiversity genomics, the Smithsonian hopes to raise $100 million
over the next 10 years.
Dec 12 | Bio-IT World | The Molecular Medicine Tri-Conference in San Francisco has a rich agenda with four content channels in addition to short courses and symposia. This year we are particularly interested in the Informatics Channel. Here’s the working draft of our agenda.
Dec 11 | Bio-IT World | Data generated by the International Cancer Genome Consortium, including whole genomes, exomes, and RNA-seq, will now be made available to researchers through Annai Systems' ShareSeq platform.
Dec 09 | Bio-IT World | Researchers from
Arizona State University and IBM’s TJ Watson Research Center present the
development of a solid state tunneling device sensitive to nucleotides. The
next steps may reveal the direction in which nanopore sequencing is heading.
Dec 08 | Boston Herald | Most parents would like to have
their newborns genetically tested for medical conditions and
disorders, according to a new study published this wee
Dec 08 | Bio-IT World | BaseHealth of Redwood City, Calif., has announced a partnership with the European diagnostics network Labco to deploy BaseHealth’s Genophen platform to thousands of physicians across Europe
Dec 08 | Omics! Omics! Blog | Keith Robison: "It's sobering
to think how few of the targets of current therapeutics could be
found from genomics data."
Dec 05 | MIT Technology Review | As Editas Medicine claims exclusive licenses to use key intellectual property around the CRISPR-Cas9 gene editing system, many of the innovators of this technology are disputing patent priority, or even the right to patent foundational CRISPR engineering techniques.
Dec 04 | Forbes | Former pharmaceutical executive Fred
Eshelman has pledged $100 million to spur innovation at the UNC's
Dec 04 | Bio-IT World | Eric Alm, co-director of the new Center for Microbiome Informatics and Therapeutics at MIT and MGH, talks microbial therapies, new regulatory models, and the public appeal of our microbes.
Dec 02 | Bio-IT World | Editas Medicine, a Cambridge company tackling therapies based on CRISPR gene editing, announced three intellectual property licensing deals with major research institutions this week, gaining exclusive access to key CRISPR-related technologies.